Search research articles
Contact Us
Filters
Showing results (101-110 of 135) with videos related to
Page
of 14
Sort By:
Melanoma Research
|
April 2, 2004
Cutaneous malignant melanoma and neurofibromatosis type 1
Bernard Guillot, Sophie Dalac, Michele Delaunay, et al.
Dermatology (Basel, Switzerland)
|
April 15, 2015
Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients
Saskia Ingen-Housz-Oro, Julie Plée, Thibaut Belmondo, et al.
The New England Journal of Medicine
|
February 1, 2002
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
Pascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Frontiers in Immunology
|
April 26, 2019
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
Delphine Giusti, Estela Bini, Christine Terryn, et al.
Archives of Dermatology
|
September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study
Julie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Journal of Cosmetic Dermatology
|
July 3, 2020
Purple tulip extract improves signs of skin aging through dermal structural modulation as shown by genomic, protein expression and skin appearance of volunteers studied
Neïla Hajem, Léana Manzato, Marie-Christine Branchet, et al.
Journal of Medicinal Chemistry
|
January 9, 2009
Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue
Florence Popowycz, Guy Fournet, Cédric Schneider, et al.
European Journal of Medicinal Chemistry
|
July 21, 2007
Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
Pierre Raboisson, Dominique Schultz, Christian Muller, et al.
Archives of Dermatology
|
September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France
Florent Grange, Coralie Barbe, Francois Aubin, et al.
Scientific Reports
|
December 10, 2019
Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid
Nicolas Berkani, Pascal Joly, Marie-Laure Golinski, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 135) with videos related to
Sort By:
Page
of 14
Melanoma Research
|
April 2, 2004
Cutaneous malignant melanoma and neurofibromatosis type 1
Bernard Guillot, Sophie Dalac, Michele Delaunay, et al.
Dermatology (Basel, Switzerland)
|
April 15, 2015
Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients
Saskia Ingen-Housz-Oro, Julie Plée, Thibaut Belmondo, et al.
The New England Journal of Medicine
|
February 1, 2002
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
Pascal Joly, Jean-Claude Roujeau, Jacques Benichou, et al.
Frontiers in Immunology
|
April 26, 2019
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
Delphine Giusti, Estela Bini, Christine Terryn, et al.
Archives of Dermatology
|
September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study
Julie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Journal of Cosmetic Dermatology
|
July 3, 2020
Purple tulip extract improves signs of skin aging through dermal structural modulation as shown by genomic, protein expression and skin appearance of volunteers studied
Neïla Hajem, Léana Manzato, Marie-Christine Branchet, et al.
Journal of Medicinal Chemistry
|
January 9, 2009
Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue
Florence Popowycz, Guy Fournet, Cédric Schneider, et al.
European Journal of Medicinal Chemistry
|
July 21, 2007
Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
Pierre Raboisson, Dominique Schultz, Christian Muller, et al.
Archives of Dermatology
|
September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France
Florent Grange, Coralie Barbe, Francois Aubin, et al.
Scientific Reports
|
December 10, 2019
Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid
Nicolas Berkani, Pascal Joly, Marie-Laure Golinski, et al.
Page
of 14